News
PRE
19.87
+0.76%
0.15
Weekly Report: what happened at PRE last week (0615-0619)?
Weekly Report · 3d ago
Prenetics Global Price Target Announced at $30.00/Share by Benchmark
Dow Jones · 06/16 13:21
Prenetics Global Initiated at Buy by Benchmark
Dow Jones · 06/16 13:21
Benchmark Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $30
Benzinga · 06/16 13:11
Prenetics initiated with a Buy at Benchmark
TipRanks · 06/16 10:25
Prenetics files Form 3 as director Hudson Blake Leogrande reports 24,004 RSUs
PUBT · 06/15 16:26
Weekly Report: what happened at PRE last week (0608-0612)?
Weekly Report · 06/15 10:21
NewGenIvf appoints four independent directors to board
PUBT · 06/11 12:31
Prenetics Global Affirms Q2 Sales Guidance of $46.000M-$48.000M vs $37.849M Est
Benzinga · 06/10 21:38
Prenetics Global Q1 EPS $(1.61) Misses $(0.82) Estimate, Sales $35.954M Miss $37.849M Estimate
Benzinga · 06/10 21:35
Prenetics posts revenue growth, lifts 2026 outlook
Seeking Alpha · 06/10 14:39
Prenetics Posts Record Q1 2026 as IM8 Surges and Guidance Raised
TipRanks · 06/10 12:58
Supplements maker Prenetics' Q1 revenue surges on IM8 growth, raises outlook
Reuters · 06/10 12:46
PRENETICS GLOBAL Q1 EPS USD -1.36
Reuters · 06/10 12:34
Prenetics Q1 2026 operating loss narrows to USD 8.87 million; revenue rises to USD 35.95 million
PUBT · 06/10 12:32
PRENETICS GLOBAL - RAISES FULL-YEAR 2026 IM8 REVENUE GUIDANCE TO $190 MLN-$210 MLN
Reuters · 06/10 12:30
Weekly Report: what happened at PRE last week (0601-0605)?
Weekly Report · 06/08 10:17
Prenetics names Comfrt CEO Hudson Leogrande to board as independent director
PUBT · 06/04 12:32
PRENETICS APPOINTS HUDSON LEOGRANDE, FOUNDER AND CEO OF MULTI-BILLION-DOLLAR DTC BRAND COMFRT, TO BOARD OF DIRECTORS AS IM8 ACCELERATES TIKTOK AND META EXPANSION
Reuters · 06/04 12:30
Weekly Report: what happened at PRE last week (0525-0529)?
Weekly Report · 06/01 10:21
More
Webull provides a variety of real-time PRE stock news. You can receive the latest news about Prenetics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRE
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.